Snap-To-It Probes
卡扣式探头
基本信息
- 批准号:7501444
- 负责人:
- 金额:$ 36.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-05-01 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:AreaBRCA1 geneBindingCharacteristicsChemistryClinicalCollaborationsDNADNA ProbesDevelopmentDiagnosticDissociationEnvironmental Engineering technologyEquilibriumExhibitsFluorescenceGelGene ExpressionGlassHistidineIn SituKineticsLabelLettersMalignant NeoplasmsMeasuresMethodsMolecularMonitorMutationNickelNitrilotriacetic AcidNucleic Acid ProbesNucleic AcidsNucleotidesOligonucleotide MicroarraysOligonucleotide ProbesPeptide Nucleic AcidsPerformancePhasePolymerase Chain ReactionPositioning AttributeProcessRelative (related person)Small Business Funding MechanismsSmall Business Innovation Research GrantSolidSolutionsSpecificityStagingStandards of Weights and MeasuresSynthesis ChemistryTechnologyTemperatureTestingThermodynamicsTumor Suppressor GenesUniversitiesWashingtonbasecyanine dyedensitydesignfundamental researchiminodiacetic acidimprovedindexingmeltingnovelphosphoramiditeprogramsprototyperesearch studysuccesstool
项目摘要
DESCRIPTION (provided by applicant): Microarrays offer the potential to profile genetic alterations in a highly multiplexed format, but have suffered from sub-optimal specificity of target capture. Array technologies which improve the specificity of target capture will be of commercial value by allowing the manufacture of arrays with superior performance characteristics. We propose to develop a novel Snap-To-It array technology that consists of arrayed PNA and DNA probes that are conformationally constrained by an intra-molecular chelate. Binding to target results in the chelate dissociation and the probe snapping to the target nucleic acid in what is an all-or-none mechanism. Consistent with previous, solution phase, thermodynamic studies using Snap-To-It probes, we hypothesize that constrained probes immobilized on an array will exhibit superior target specificity compared to unconstrained probes. The proposed chelate motifs are easily introduced into arrays using existing standard array synthesis methods with only a few additional process steps. Further, chelate binding is orthogonal to Watson-Crick pairing, and thus will not interfere with target hybridization. Phase I demonstrated feasibility of Snap-To-It probes and set the stage to move into an intensive Phase II program involving the development and testing of prototype Snap-To-It arrays for cancer analysis.
DNA probes in solution and in high-throughput microarrays are invaluable tools used in areas from clinical diagnostics to fundamental research. The Snap-To-It probe technology we propose will produce microarrays with superior performance characteristics.
描述(由申请人提供):微阵列提供了高度多重格式的遗传变化的潜力,但遭受了目标捕获的次优特异性。通过允许具有出色性能特征的阵列制造阵列,可以提高目标捕获特异性的阵列技术将具有商业价值。我们建议开发一种新型的快速阵列技术,该技术由阵列的PNA和DNA探针组成,这些探针在构象上受到分子内螯合物的构象约束。与靶向目标的结合导致螯合物解离,并在全或任何人的机制中捕获靶核酸。与使用SNAP-TO-IT探针的先前的溶液相,热力学研究一致,我们假设与无约束的探针相比,固定在阵列上的探针的约束将表现出优异的靶标特异性。使用现有的标准阵列合成方法,可以轻松地引入所提出的螯合图案,并具有一些其他过程步骤。此外,螯合结合与Watson-Crick配对是正交的,因此不会干扰目标杂交。第一阶段证明了快速到IT探针的可行性,并为进入密集的II期计划奠定了基础,该计划涉及开发和测试用于癌症分析的原型Snap-to-IT阵列。
溶液和高通量微阵列中的DNA探针是从临床诊断到基础研究的领域中使用的宝贵工具。我们提出的快速探测技术将产生具有较高性能特征的微阵列。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joel R Morgan其他文献
Joel R Morgan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joel R Morgan', 18)}}的其他基金
Transition-State Analogue Inhibitors of Dihydrofolate Synthetase for MDR/XDR TB
用于治疗 MDR/XDR TB 的二氢叶酸合成酶过渡态类似物抑制剂
- 批准号:
8317529 - 财政年份:2011
- 资助金额:
$ 36.38万 - 项目类别:
Transition-State Analogue Inhibitors of Dihydrofolate Synthetase for MDR/XDR TB
用于治疗 MDR/XDR TB 的二氢叶酸合成酶过渡态类似物抑制剂
- 批准号:
8121904 - 财政年份:2011
- 资助金额:
$ 36.38万 - 项目类别:
99mTc-DTB-Antifol-Pteroyls (RadioDAPs): Theranostics for Rheumatoid Arthritis
99mTc-DTB-Antifol-Pteroyls(RadioDAP):类风湿关节炎的治疗诊断
- 批准号:
7906159 - 财政年份:2010
- 资助金额:
$ 36.38万 - 项目类别:
99mTc-DTB-Antifol-Pteroyls (RadioDAPs): Theranostics for Rheumatoid Arthritis
99mTc-DTB-Antifol-Pteroyls(RadioDAP):类风湿关节炎的治疗诊断
- 批准号:
8133718 - 财政年份:2010
- 资助金额:
$ 36.38万 - 项目类别:
PhotoMorph3 and PhotoPS3 - Novel Light-Activated Antisense Agents
PhotoMorph3 和 PhotoPS3 - 新型光激活反义剂
- 批准号:
7747829 - 财政年份:2009
- 资助金额:
$ 36.38万 - 项目类别:
相似国自然基金
BRCA1/2基因不同突变位点对对侧乳腺癌发病风险的差异影响及其机制探索
- 批准号:82372717
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
调控BRCA1突变乳腺癌PARP抑制剂应答的关键增强子及其下游基因研究
- 批准号:
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:
调控BRCA1突变乳腺癌PARP抑制剂应答的关键增强子及其下游基因研究
- 批准号:82330090
- 批准年份:2023
- 资助金额:220.00 万元
- 项目类别:重点项目
BRCA1单倍剂量不足效应诱导产生的机制及其与基因组不稳定和杂合突变致癌的联系
- 批准号:
- 批准年份:2021
- 资助金额:54.7 万元
- 项目类别:面上项目
BRCA1单倍剂量不足效应诱导产生的机制及其与基因组不稳定和杂合突变致癌的联系
- 批准号:82172951
- 批准年份:2021
- 资助金额:55.00 万元
- 项目类别:面上项目
相似海外基金
Platform to support clinical variant interpretation through probabilistic assessment of functional evidence
通过功能证据的概率评估支持临床变异解释的平台
- 批准号:
10546337 - 财政年份:2022
- 资助金额:
$ 36.38万 - 项目类别:
The Role of ZEB1 in promoting therapeutic resistance through its interaction with 53BP1
ZEB1 通过与 53BP1 相互作用促进治疗耐药的作用
- 批准号:
10551845 - 财政年份:2022
- 资助金额:
$ 36.38万 - 项目类别:
The Role of ZEB1 in promoting therapeutic resistance through its interaction with 53BP1
ZEB1 通过与 53BP1 相互作用促进治疗耐药的作用
- 批准号:
10445498 - 财政年份:2022
- 资助金额:
$ 36.38万 - 项目类别:
Identifying new drivers of ovarian cancer from the non-coding genome by converging germline risk variants and somatic mutations
通过融合种系风险变异和体细胞突变,从非编码基因组中识别卵巢癌的新驱动因素
- 批准号:
10115485 - 财政年份:2021
- 资助金额:
$ 36.38万 - 项目类别:
Mechanisms of the BRCA-network in tumorigenesis and therapeutic response
BRCA 网络在肿瘤发生和治疗反应中的机制
- 批准号:
10599895 - 财政年份:2021
- 资助金额:
$ 36.38万 - 项目类别: